An emerging medical device company currently developing a novel endovascular coaxial connector for venous anastomosis.
Phraxis is an emerging medical device company dedicated to advancing patient care through innovative solutions in vascular access. Specializing in hospitals and healthcare, Phraxis focuses on developing cutting-edge technologies like the EndoForce™ Venous Anastomotic Connector, designed to improve outcomes for patients requiring hemodialysis. With a commitment to excellence and a vision for the future, Phraxis is poised to make a significant impact on the healthcare industry.
Located in Minneapolis, Minnesota, Phraxis is driven by a mission to enhance the quality and longevity of vascular access procedures. The company’s primary address is in Minneapolis, Minnesota, US. The EndoForce™ connector represents a significant advancement in addressing neointimal hyperplasia-induced stenosis associated with conventional sutured venous anastomosis. Phraxis is dedicated to delivering procedural techniques that benefit both healthcare providers and patients.
Phraxis is actively seeking FDA approval to bring its innovative technologies to market. The team at Phraxis is committed to improving the lives of patients worldwide. We invite the management of Phraxis to create a customized and exclusive company showcase and product listing on our platform, providing an opportunity to further highlight their contributions to the medical field.
Other organizations in the same industry
This company is also known as